Delivery Order SPE2DB22D1041-SPE2DB25FUCJ6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,426.24 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) with a firm fixed price structure. The contract was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $4,513.88. This competitively awarded, firm fixed-price delivery order was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $3,021.94 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-12.5 mg tablets, 30-count unit dose packages. This competitively awarded, firm fixed-price delivery order was executed on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's competitive standing in...
- The Defense Logistics Agency awarded a delivery order valued at $3,684.92 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This competitive, non-set-aside contract utilizes firm fixed pricing and requires completion by September 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $3,549.93 delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count unit dose packaging) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery location is specified as Conshohocken, PA, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,215.19 on August 22, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,833.03 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,007.04 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packages of 30 units. This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $6,021.48 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract requires performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,141.02 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation, reflecting open competition...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUCJ6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,095.44 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablet unit dose in quantities of 30, with an ultimate completion date of September 25, 2025. This is a firm fixed price, non-set-aside competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The parent IDC with DLA Troop Support Medical functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs. This delivery order represents a routine transaction under that master contract, reflecting AmerisourceBergen's established capability to fulfill federal pharmaceutical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.1k | 9/24/25 |